22nd Century Group (XXII) Stock Price

22nd Century Group Price

NYSE AMEX·CLOSED
0.28
​
Market closed

Revenue has compounded at 14.9% per year over the past 14 years to 7.05 M USD. 22nd Century Group's net margin stands at -71.7%, up from -105.4% several years earlier.

22nd Century Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

22nd Century Group business model & stock analysis

22nd Century Group, Inc. develops biotechnology solutions for tobacco and cannabis plants, focusing on genetic engineering to adjust nicotine levels in tobacco and cannabinoid levels in cannabis. The company creates products like RED SUN and MAGIC cigarettes, which it manufactures, markets, and distributes. It also produces SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA) and offers contract manufacturing for third-party branded tobacco products. The firm's revenue streams include sales of its branded cigarettes, research cigarette production, and contract manufacturing services. The company's primary customers are consumers of its RED SUN and MAGIC cigarette brands, research institutions like NIDA, and third-party tobacco brands seeking contract manufacturing. Its product lines target segments interested in reduced nicotine content for smoking cessation and research purposes. The X-22 smoking cessation aid, featuring very low nicotine (VLN) cigarettes, represents a key product in its portfolio aimed at helping users reduce nicotine dependency. 22nd Century Group's business model revolves around selling its proprietary tobacco products, providing research-grade cigarettes for scientific studies, and fulfilling manufacturing contracts for other brands. The company's focus on genetic engineering for nicotine reduction positions it within the market for less harmful tobacco alternatives, while its contract manufacturing services diversify its revenue sources beyond direct consumer sales.

Frequently asked questions about 22nd Century Group

7 analysts currently rate the 22nd Century Group stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the 22nd Century Group share trades at 0.25 EUR (0.28 USD).

The 22nd Century Group share (XXII) is listed on 3 stock exchanges, including: NASDAQ (XXII), Frankfurt (22N.F).

The revenue cannot currently be calculated for 22nd Century Group.

The expected profit of 22nd Century Group is -360.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of 22nd Century Group is currently -1.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the 22nd Century Group stock.

The P/S cannot be calculated for 22nd Century Group currently.

The Eulerpool Quality Score for 22nd Century Group is 2/10.

The ISIN of 22nd Century Group is US90137F6088. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of 22nd Century Group is A1W2NQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of 22nd Century Group is XXII. The ticker symbol is used to trade 22nd Century Group shares on the stock exchange.

Fair ValueTerminal
0.23 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Tobacco
Number of shares
Employees
Revenue per Employee
220,281.25 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 17, 2006
ISIN
US90137F6088
Cusip
90137F103
Sedol
B1FH4T9
Market capitalization
111.08 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-1.21
P/Ee 2027
—
P/S
P/Se
—
EV/EBIT
0.25
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-25.31 %
Last updated Oct 22, 2026, 10:15 AM

22nd Century Group Ticker

AMEX · XXIIFRANKFURT · 22N.FNASDAQ · XXII